Azienda Ospedaliera Istituti Ospitalieri di Cremona

Cremona 26100

1 studies enrolling now · 7 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Castration-Resistant Prostate Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, Ischemic Stroke; Ischemic Attack, Transient, Non-Small Cell Lung Cancer, Prostate Cancer, Squamous Cell Carcinoma, Non-Small-Cell Lung

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer — Completed
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
• Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer — Completed